Personalized Reference Intervals in Laboratory Medicine: A New Model Based on Within-Subject Biological Variation
Yükleniyor...
Tarih
Süreli Yayın başlığı
Süreli Yayın ISSN
Cilt Başlığı
ISSN
Cilt
67
Sayı
2
FEB
FEB
Yayınevi
Özet
BACKGROUND: The concept of personalized medicine has received widespread    attention in the last decade. However, personalized medicine depends on    correct diagnosis and monitoring of patients, for which personalized    reference intervals for laboratory tests may be beneficial. In this    study, we propose a simple model to generate personalized reference    intervals based on historical, previously analyzed results, and data on    analytical and within-subject biological variation.    METHODS: A model using estimates of analytical and within-subject    biological variation and previous test results was developed. We modeled    the effect of adding an increasing number of measurement results on the    estimation of the personal reference interval. We then used laboratory    test results from 784 adult patients (>18 years) considered to be in a    steady-state condition to calculate personalized reference intervals for    27 commonly requested clinical chemistry and hematology measurands.    RESULTS: Increasing the number of measurements had little impact on the    total variation around the true homeostatic set point and using >= 3    previous measurement results delivered robust personalized reference    intervals. The personalized reference intervals of the study    participants were different from one another and, as expected, located    within the common reference interval. However, in general they made up    only a small proportion of the population-based reference interval.    CONCLUSIONS: Our study shows that, if using results from patients in    steady state, only a few previous test results and reliable estimates of    within-subject biological variation are required to calculate    personalized reference intervals. This may be highly valuable for    diagnosing patients as well as for follow-up and treatment.
